During the past decade, Instituto Jalisciense de Investigacion en Diabetes y Obesida conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 5 clinical trials were completed, i.e. on average, 55.6% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 4 clinical trials were completed. i.e. 57.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Instituto Jalisciense de Investigacion en Diabetes y Obesida" #1 sponsor was "Eli Lilly and Company" with 5 trials, followed by "Pfizer" with 2 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored, "Gilead Sciences" with 1 trials sponsored and "Immunic AG" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

According to Clinical.Site data, the most researched conditions in "Instituto Jalisciense de Investigacion en Diabetes y Obesida" are "Type 2 Diabetes Mellitus" (3 trials), "COVID-19" (2 trials), "Type 2 Diabetes" (2 trials), "Multiple Sclerosis" (1 trials) and "Obesity" (1 trials). Many other conditions were trialed in "Instituto Jalisciense de Investigacion en Diabetes y Obesida" in a lesser frequency.

Most popular intervention types in "Instituto Jalisciense de Investigacion en Diabetes y Obesida" are "Drug" (9 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Tirzepatide" (5 trials), "PF-07321332" (2 trials), "Placebo" (2 trials), "Ritonavir" (2 trials) and "Diet" (1 trials). Other intervention names were less common.

The vast majority of trials in "Instituto Jalisciense de Investigacion en Diabetes y Obesida" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Instituto Jalisciense de Investigacion en Diabetes y Obesida". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Instituto Jalisciense de Investigacion en Diabetes y Obesida, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Instituto Jalisciense de Investigacion en Diabetes y Obesida, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".